🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Urgent need for updated guidelines on Systemic Anticancer Therapy use at #EndofLife: Our study of 68,000+ patients found use of novel SACT at EOL, including immunotherapy, was associated with indicators of poor-quality #EndofLifeCare. doi.org/10.1200/JCO-24… Journal of Clinical Oncology The Princess Margaret Cancer Foundation

Excellent work! Congratulations Regina Barragan-Carrillo Alex Chehrazi-Raffle, MD

↔️ Watch out for those 2!! 😅 Matteo Santoni ARON project #RCC #KidneyCancer #ASCO25 ASCO The ASCO Post

There's still time to join GRASP Scientist and Poster Author Romualdo Barroso, MD PhD on June 12 at 10:00 as we discuss practice-changing data in HER2+ Breast Cancer. Register today! graspcancer.org/events/asco25-… #asco #asco2025 #bcsm #registertoday #GRASPPosters #GRASPatASCO #her2 #adcs

How to crush a PSMA PET report: Guidelines and scoring systems. Presentation by Phillip Kuo, MD, PhD, FACR City of Hope addressing standardized PSMA PET reporting across clinical and research contexts. #WatchNow > bit.ly/4n1xa12 PSMA and Beyond Conference #2025PSMAandBeyond

Beyond Opioids: A Multidisciplinary Approach to #Cancer Pain Management. ascopubs.org/doi/pdf/10.120… ASCO Journal of Clinical Oncology JCO Oncology Practice #PallOnc #CancerCare #CancerResearch #SuppOnc Desiree Azizoddin, PsyD Dana-Farber

Most individuals with pancreatic cancer loses muscle mass and become cachexic. Article does a great job going into detail of the interplay between the cancer and muscle loss at the molecular level. Overall cachexia is deadly. Up to 80% of pancreatic cancer patients develop

📢 Just published in Journal of the @NCCN ! Our RCT shows that a telehealth GA & #SuppCare Intervention (GAIN-S) improved physical function, mood & QoL in older Brazilians with metastatic cancer William Dale, MD, PhD, FASCO Enrique Soto Areej El-Jawahri Ryan Nipp, MD, MPH, MBA, FASCO jnccn.org/view/journals/…

Older adults in their late 60s who resistance train have similar lower-body strength (sit-to-stand), endurance, and stair-climbing ability as younger people aged in their 20s.

Not only exercise helps to reduce depression, but it also helps with anxiety as well. We get the release of endorphins that uplift our mood. In addition, exercise helps to regular cortisol and adrenaline which is linked to stress and anxiety. Exercise also helps to enhance

Grateful to CURE Today to highlight #STELLAR002 novel doublet/triplet #Zanza + #Nivo +/- #RELA (LAG3) in 1L ccRCC 📌 Doublet/triplet favorable AE profiel w/ 5-18% d/c rate 📌 #Zanza + Nivo +/- Rela led to DCR 90% and 12mo PFS 58-64% Outstanding questions: ❓What is role of

Very excited the primary psychosocial outcomes of the MATCH (Mindfulness and Taichi for Cancer Health) trial were published today in the ASCO Journal of Clinical Oncology. Largest comparative trial of #mindbody therapies to date. Free full-text here: ascopubs.org/doi/pdf/10.120…

The best #ValentinesDay gift ever (it’s today in 🇧🇷) from Cristiane D Bergerot 🥰 An ExIO study mug featuring our paper at Supportive Care in Cancer: Springer Journal!! #DiaDosNamorados” link.springer.com/article/10.100…

Paulo G Bergerot Cristiane D Bergerot Supportive Care in Cancer: Springer Journal Narjust Florez, MD, FASCO Dr Kathryn Schmitz Awe love this!

A comprehensive review about the role of tumor microenvironment on the immunotherapy response! OncoAlert Nature Cancer #Cancer #Oncology #MedTwitter nature.com/articles/s4301…

Congratulations to Toni Choueiri, MD on being the recipient of a Doctorate Honoris Causa from The Lebanese University recognizing his outstanding achievements in Oncology.

🔥 Breakthrough in extensive-stage small-cell lung cancer maintenance! 🫁Lurbinectedin + Atezolizumab doubled PFS vs Atezolizumab alone! 🫁OS benefit also significant (13.2 vs 10.6 mo) 💥 First phase 3 trial to improve both PFS & OS in 1L maintenance for ES-SCLC. OncoAlert

A non-androgen targeted approach might be an alternative in patients with metastatic castration resistant prostate cancer who have progressive disease with ARPI❓ CONTACT-02 Phase ⤵️ ✅Cabozantinib + atezolizumab significantly improved progression-free survival vs ARPI switch

Quality of Informed Consent via #Telemedicine Compared With In-Person for Clinical #Cancer Research. ascopubs.org/doi/10.1200/OP… ASCO Journal of Clinical Oncology JCO Oncology Practice #CancerResearch #Telehealth Memorial Sloan Kettering Cancer Center Andrew Vickers

What a full-circle moment. My mentee as first author. My mentor as senior author. Proud to stand between @EmreYekeduz and Toni Choueiri, MD—and alongside esteemed colleagues—on this important study in mRCC and comorbidities. Science. Mentorship. Meaning. Together. #Oncology #RCC